Willemien V. Van Driel-Driel - Publications

Tumour microenvironment characterisation to stratify patients for hyperthermic intraperitoneal chemotherapy in high-grade serous ovarian cancer (OVHIPEC-1).

Journal: British journal of cancer

Published: December 19, 2023

Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer - Authors' reply.

Journal: The Lancet. Oncology

Published: November 06, 2023

Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2).

Journal: Annals of surgical oncology

Published: November 03, 2022

Turning up the heat does not affect quality of life.

Journal: Journal of gynecologic oncology

Published: June 15, 2022

Peroperative scoring systems for predicting the outcome of cytoreductive surgery in advanced-stage ovarian cancer - A systematic review.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: January 08, 2021

Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 06, 2020

No influence of sarcopenia on survival of ovarian cancer patients in a prospective validation study.

Journal: Gynecologic oncology

Published: May 08, 2020

The role of hyperthermic intraperitoneal intraoperative chemotherapy in ovarian cancer.

Journal: Current treatment options in oncology

Published: March 23, 2015

Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovary.

Journal: Gynecologic oncology

Published: April 09, 2014